Xylodex Regeneration nasal spray 1 mg/50 mg 10 ml

Xylodex Regeneration nasal spray 1 mg/50 mg 10 ml

100% secure payments
zł25.07
Tax included

Description

Xylodex Regeneration nasal spray 1 mg/50 mg 10 ml

Description
Composition and form: Xylodex 0.05% regeneration: Each ml of solution contains 0.50 mg of xylometazoline hydrochloride and 50.0 mg of dexopanthenol. Each dose of nasal spray (0.1 ml of solution) contains 0.05 mg of xylometazoline hydrochloride and 5.0 mg of dexopanthenol. Excipient with known effect: benzalkonium chloride 0.2 mg/ml. Xylodex 0.1% regeneration: Each ml of solution contains 1.0 mg of xylometazoline hydrochloride and 50.0 mg of dexopanthenol. Each dose of nasal spray (0.1 ml of solution) contains 0.1 mg of xylometazoline hydrochloride and 5.0 mg of dexpanthenol. Excipient with known effect: benzalkonium chloride 0.2 mg/ml. Nasal spray, solution. Colorless or almost colorless, transparent solution.

Indications: Xylodex 0.05% regeneration and Xylodex 0.1% regeneration are indicated for the symptomatic treatment of nasal obstruction in the course of a cold and after nasal surgery - to stimulate the healing of the mucous membrane and improve nasal patency. Xylodex 0.05% regeneration is indicated for use in children aged 2 to 6 years. Xylodex 0.1% regeneration is indicated for use in adults and children from 6 years of age.
Storage and use
How to use: Use as directed by your doctor
Detailed instructions for use can be found in the leaflet included in the package.

Storage: Store at ambient temperature
Composition
Dexpanthenol
Manufacturer
Polfa Warszawa S.A.
Manufacturer address
Polfa Warszawa S.A.,
street Karolkowa 22/24,
01-207 Warszawa,
EN
Security Warning
Particular caution should be exercised when using Xylodex 0.05% regeneration or Xylodex 0.1% regeneration in case of: taking monoamine oxidase inhibitors (MAOIs) or other drugs that may cause increased blood pressure, increased intraocular pressure, especially in the case of narrow-angle glaucoma, diseases of the cardiovascular system (ischemic heart disease, hypertension), pheochromocytoma of the adrenal glands, metabolic diseases (e.g. hyperthyroidism, diabetes), hypersensitivity to sympathomimetic substances. The use of the product in people with such hypersensitivity may cause insomnia, dizziness, tremors, heart rhythm disturbances and increased blood pressure, patients with porphyria, patients with prostatic hyperplasia. Patients with long QT syndrome treated with xylometazoline may be at increased risk of severe ventricular arrhythmias. Do not use doses higher than recommended. Due to the risk of atrophy of the nasal mucosa, the medicinal product should be used in chronic rhinitis only under medical supervision. Long-term use of sympathomimetic drugs or their use in doses higher than recommended may cause reactive nasal congestion and, consequently, narrowing of the airways. The "rebound effect" leading to narrowing of the respiratory tract causes the patient to continue using the product repeatedly until its use becomes permanent, resulting in secondary drug-induced rhinitis medicamentosa or even atrophy of the nasal mucosa. In milder cases of reactive nasal congestion, it may be appropriate to discontinue the sympathomimetic drug first in one nostril (to keep part of the nose open) and then in the other nostril after symptoms have resolved. Due to the risk of transmitting infection, the drug package should be used by one patient only. The product contains 0.2 mg of benzalkonium chloride in each ml of solution. Benzalkonium chloride may cause irritation or swelling of the nasal mucosa, especially if used for a long time.

Product Details

Polpharma
15 Items

Specific References

EAN13
5909991058579

Reviews

No customer reviews for the moment.